Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Assets (2016 - 2025)

Historic Current Assets for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $472.4 million.

  • Standard Biotools' Current Assets rose 415.16% to $472.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $472.4 million, marking a year-over-year increase of 415.16%. This contributed to the annual value of $375.9 million for FY2024, which is 13757.73% up from last year.
  • Standard Biotools' Current Assets amounted to $472.4 million in Q3 2025, which was up 415.16% from $506.0 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Current Assets ranged from a high of $547.6 million in Q1 2024 and a low of $72.1 million during Q4 2021
  • Moreover, its 5-year median value for Current Assets was $208.8 million (2022), whereas its average is $261.5 million.
  • As far as peak fluctuations go, Standard Biotools' Current Assets crashed by 4010.83% in 2021, and later skyrocketed by 22079.0% in 2022.
  • Quarter analysis of 5 years shows Standard Biotools' Current Assets stood at $72.1 million in 2021, then surged by 189.76% to $208.8 million in 2022, then fell by 24.23% to $158.2 million in 2023, then skyrocketed by 137.58% to $375.9 million in 2024, then increased by 25.69% to $472.4 million in 2025.
  • Its Current Assets stands at $472.4 million for Q3 2025, versus $506.0 million for Q2 2025 and $344.0 million for Q1 2025.